CN103719863A - Preparation method of red ginseng chewable tablets - Google Patents
Preparation method of red ginseng chewable tablets Download PDFInfo
- Publication number
- CN103719863A CN103719863A CN201410005921.7A CN201410005921A CN103719863A CN 103719863 A CN103719863 A CN 103719863A CN 201410005921 A CN201410005921 A CN 201410005921A CN 103719863 A CN103719863 A CN 103719863A
- Authority
- CN
- China
- Prior art keywords
- red ginseng
- powder
- aspartame
- korean red
- liquid extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000002789 Panax ginseng Nutrition 0.000 title claims abstract description 44
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000000284 extract Substances 0.000 claims abstract description 19
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 18
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 18
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 18
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 18
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 18
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 18
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 18
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 18
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 18
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 18
- 108010011485 Aspartame Proteins 0.000 claims abstract description 14
- 239000000605 aspartame Substances 0.000 claims abstract description 14
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 14
- 235000010357 aspartame Nutrition 0.000 claims abstract description 14
- 229960003438 aspartame Drugs 0.000 claims abstract description 14
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 9
- 229920002472 Starch Polymers 0.000 claims abstract description 9
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims abstract description 9
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims abstract description 9
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 9
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229940041616 menthol Drugs 0.000 claims abstract description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 9
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 9
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 9
- 235000013336 milk Nutrition 0.000 claims abstract description 9
- 239000008267 milk Substances 0.000 claims abstract description 9
- 210000004080 milk Anatomy 0.000 claims abstract description 9
- 239000011734 sodium Substances 0.000 claims abstract description 9
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 9
- 239000008107 starch Substances 0.000 claims abstract description 9
- 235000019698 starch Nutrition 0.000 claims abstract description 9
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 3
- 239000007788 liquid Substances 0.000 claims description 16
- 235000009508 confectionery Nutrition 0.000 claims description 13
- 244000185386 Thladiantha grosvenorii Species 0.000 claims description 11
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims description 10
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 4
- 239000007884 disintegrant Substances 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000011122 softwood Substances 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 235000020985 whole grains Nutrition 0.000 claims description 4
- 235000013402 health food Nutrition 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 238000012827 research and development Methods 0.000 abstract description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 2
- 229930195725 Mannitol Natural products 0.000 abstract 2
- 239000012530 fluid Substances 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 239000000594 mannitol Substances 0.000 abstract 2
- 235000010355 mannitol Nutrition 0.000 abstract 2
- 238000001035 drying Methods 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000007779 soft material Substances 0.000 abstract 1
- 238000005728 strengthening Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 18
- 241001092040 Crataegus Species 0.000 description 15
- 230000001093 anti-cancer Effects 0.000 description 9
- 235000008434 ginseng Nutrition 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 5
- 240000004371 Panax ginseng Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229930192392 Mitomycin Natural products 0.000 description 2
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229960004857 mitomycin Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241001409305 Siraitia Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000007688 immunotoxicity Effects 0.000 description 1
- 231100000386 immunotoxicity Toxicity 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229930189775 mogroside Natural products 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of research and development of health food, and relates to a preparation method of red ginseng chewable tablets. The method comprises the following steps: uniformly mixing mannitol powder and aspartame, passing through a 100-mesh screen for later use, uniformly mixing red ginseng ultrafine powder, hawthorn fluid extract, fructus momordicae fluid extract, milk powder, microcrystalline cellulose or sodium carboxymethyl starch and menthol with the mannitol powder and aspartame, adding hydroxypropyl methylcellulose and a right amount of ethanol to prepare a soft material, granulating, drying, finishing the granules, adding magnesium stearate, evenly mixing, tabletting with a tabletting machine, and packaging. The product has the function of strengthening the body.
Description
Technical field
Health food research and development technical field under the present invention.The present invention relates to a kind of preparation method of Korean red ginseng chewable tablets.Product of the present invention has the function improving the health.
Background technology
1 Korean red ginseng system is processed through steaming, toasting by the Koryo garden ginsent that originates from Korea S, in processing Korean red ginseng process, has new anticancer active constituent to produce.Korean red ginseng is not cool not warm yet, belongs to warm nature; Though Korean ginseng is warm in nature, benefit property is strong, and beneficial gas helps fire.Korean ginseng divides again white ginseng and red ginseng, and insufficiency of the spleen hyperactivity of fire person should use white ginseng, because of " raw use gas is cool, micro-bitter tonifying yin "; The timid person of insufficiency of the spleen lung should use red ginseng, " ripe in temperature, the sweet yang-tonifying of taste ".On the whole, Korean ginseng is more suitable for the frank people of the old deficiency of vital energy and takes, and the strong physique of energy, strengthens immunity.
The effect of Korean red ginseng:
(1) brain healthy: the people that failure of memory and sports coordination ability are declined and be on the drink or the food of contact zones alcohol component, the people of medicine, Korean red ginseng has and improves mental working ability, strengthens memory and improve the effect of cerebral ischemia obstacle
(2) analgesia: some experts are by doing sensing nerve cell test discovery, and Korean ginseng is all helpful to the various pain symptoms of health.
(3) anti-cancer and anticancer: the saponin constituent of Korean red ginseng and non-saponin constituent have the proliferation activity that suppresses multiple cancer cell also can shift by inhibition cancer cell simultaneously.In addition, Korean red ginseng and anticancer are with taking, and anticancer effect is better than independent with anticancer (mitomycin).This is because cancer cell easily forms tolerance in chemotherapy of tumors, and Korean red ginseng and anticancer be with taking, and enhancing is to the lethality of cancer cell, the side effect that alleviates anticancer.
(4) strengthen immunity: Korean red ginseng extract can recover to have because of taking the cellular immunity that the anticancer (mitomycin) of immunotoxicity declines and react, especially ether extract can activate or strengthen cellular immunity, and the activity of NK, to improving immunity, there is very large effect.
(5) control diabetes: Korean red ginseng contains the material that promotes insulin secretion and similar insulin action, and wherein ginsenoside can improve hyperglycaemia, effectively controls the generation of diabetes.
(6) strong liver: have antihepatitic activity in Korean ginseng composition, there is the effect of removing toxic substances, protection liver and promotion liver regeneration, recovery.In addition, Korean red ginseng relieves the effect of alcohol, eliminates the effect of being still drank after a night in addition.
(7) regulate blood pressure: Korean red ginseng has hemangiectasis effect, can improve blood circulation, saponin constituent wherein, by promoting vascular endothelial cell to discharge nitric oxide, can reach hypotensive activity.
(8) antifatigue and resistance to compression: find after deliberation, continue to take Korean red ginseng and can improve locomitivity and fatigue-relieving, to promoting recovery and the prevention exercise induced anemia of player's fatigue accumulation to have very great help; In addition, Korean red ginseng can also strengthen the tolerance to adverse environments such as low temperature (5 ℃, O ℃ ,-10 ℃) and high temperature (35 ℃), by pressure or environmental change are carried out to exquisite adjusting, improves anti-pressure ability, maintains organism stability.
(9) improve Menopause obstacle: according to investigations, have the women of climacteric obstacle symptom after taking Korean red ginseng, have 80% people to admit to take Korean red ginseng after symptom obviously improve.Expert claims, these women, as adjusted consumption according to symptom, also can improve curative effect.
(10) improve male sexual disfunction: Korean red ginseng can prevent the male sexual disfunction causing because of pressure.Through clinical testing, erectile dysfunction patient (90 people) takes after Korean red ginseng, at aspects such as the degree of erection, sexual desire and satisfactions, all makes moderate progress.
(11) anti-oxidant and anti-ageing: Korean red ginseng has the antioxidant effect with lipid peroxidation that increases that suppresses harmful active oxygen.
2 hawthorn edible plants, matter is hard, and pulp is thin, and taste is micro-sour and astringent; Machaka, the close life of branch, has spinelet, and sprout has pubescence; Sprig puce, old branch taupe.
The nutritive value of hawthorn:
Hawthorn, containing multivitamin, crataegolic acid, tartaric acid, citric acid, malic acid etc., also contains the mineral matters such as flavonoids, lactone, carbohydrate, protein, fat and calcium, phosphorus, iron, and contained lipolytic enzyme can promote the digestion of fat food.Promote gastric secretion and increase the functions such as stomach endoenzyme element.The traditional Chinese medical science thinks, hawthorn has that long-pendingization of disappearing is stagnant, convergence only dysentery, the effect such as activate blood circulation and disperse blood clots.Cure mainly the diseases such as eating accumulation, chest diaphragm spleen are full, the amenorrhoea of hernia blood stasis.In hawthorn, contain the drug ingedients such as mountain terpene and flavonoids, there is significant hemangiectasis and hypotensive effect, have the function that strengthens cardiac muscle, arrhythmia, adjusting blood fat and cholesterol level.Accommodation: common people are edible all.Children, the elderly, indigestion be edibility especially.Cold, indigestion, poor appetite, children's cartilage acalcicosis, Iron deficiency anemia in children person can eat haw flakes more.
The effect of hawthorn and effect:
(1) prevention and cure of cardiovascular disease, reduces blood pressure and cholesterol, softening blood vessel and diuresis and sedation;
(2) appetite-stimulating indigestion-relieving, offsets carnivorous stagnant effect better especially, in a lot of digestant medicines, has all adopted hawthorn;
(3) hawthorn has the effect activating blood circulation and dispersing blood clots, and contributes to remove local extravasated blood state, and traumatic injury is had to auxiliary curative effect;
(4) in hawthorn, have relieving asthma reduce phlegm, the composition of anti-bacteria, treatment abdominal pain diarrhea.
3 Momordica grosvenori Momordica grosvenoris (formal name used at school: be Siraitia grosvenori) the distinctive precious cucurbitaceous plant of China, have the title of the good fruit of good medicine, of many uses, the market that enjoys a good market both at home and abroad, enjoys a very good reputation in the international market.It is the famous special product of Guangxi China.The traditional Chinese medical science is with its fruit medicine, contains mogroside, abundant medicinal ingredients such as glucose, fructose, several amino acids and vitamin, clearing heat and moistening lung, cough-relieving, relieve sore throat, laxation defaecation.Cure mainly lung heat phlegm-fire cough, sphagitis, tonsillitis, acute gastritis, constipation etc.With Momordica grosvenori a little, pour boiling water and soak, be a kind of fabulous cold drink, both can refresh oneself and promote the production of body fluid, again can preventing respiratory tract infection, take throughout the year, can promote longevity, arhat juice also can be used for the cooking, delicate fragrance is good to eat, Momordica grosvenori is described as " angle fruit " by people.Product of the present invention has the function improving the health.
Summary of the invention
1, a preparation method for Korean red ginseng chewable tablets, is characterized in that following steps:
(1) Korean red ginseng ultrafine powder, the hawthorn liquid extract of 3-5%, the sweet mellow wine powder of the Momordica grosvenori liquid extract of 2-5%, 10-15% milk powder, 10-50% that the percentage by weight of material component is 5-10% is that filler, 2-30% microcrystalline cellulose or sodium carboxymethyl starch are that the Aspartame of disintegrant, 1-5% is that the menthol of sweetener, 1-3% is that the dolomol of freshener, 1-3% is that the hydroxypropyl methylcellulose of lubricant, 1-3% is that the ethanol of binder, appropriate 65-75% is wetting agent;
(2) sweet mellow wine powder in (1) and Aspartame are mixed, cross 100 mesh sieves standby;
(3) Korean red ginseng ultrafine powder, hawthorn liquid extract, Momordica grosvenori liquid extract, milk powder, microcrystalline cellulose or sodium carboxymethyl starch, menthol in (1) are mixed with sweet mellow wine powder in (2) and Aspartame, add hydroxypropyl methylcellulose and appropriate ethanol to make softwood, crossing 16 mesh sieves granulates, 50-60 ℃ of dry 3-4h, crosses the whole grain of 14 mesh sieves;
(4) add dolomol to mix the particle in (3), use tablet press machine compressing tablet, packing.
According to the present invention, " % " in the present invention is percentage by weight.
The specific embodiment
The preparation method who relates to a kind of Korean red ginseng chewable tablets of the present invention comprises following examples, and the following examples can further illustrate the present invention, but do not limit the present invention in any way.
Embodiment 1:
1, a preparation method for Korean red ginseng chewable tablets, is characterized in that following steps:
(1) the Korean red ginseng ultrafine powder that the percentage by weight of material component is 5%, 3% hawthorn liquid extract, 2% Momordica grosvenori liquid extract, 15% milk powder, 50% sweet mellow wine powder are that filler, 21% microcrystalline cellulose or sodium carboxymethyl starch are that disintegrant, 1% Aspartame are that sweetener, 1% menthol are that freshener, 1% dolomol are that lubricant, 1% hydroxypropyl methylcellulose are that binder, appropriate 65% ethanol are wetting agent;
(2) sweet mellow wine powder in (1) and Aspartame are mixed, cross 100 mesh sieves standby;
(3) Korean red ginseng ultrafine powder, hawthorn liquid extract, Momordica grosvenori liquid extract, milk powder, microcrystalline cellulose or sodium carboxymethyl starch, menthol in (1) are mixed with sweet mellow wine powder in (2) and Aspartame, add hydroxypropyl methylcellulose and appropriate ethanol to make softwood, crossing 16 mesh sieves granulates, 50 ℃ of dry 3h, cross the whole grain of 14 mesh sieves;
(4) add dolomol to mix the particle in (3), use tablet press machine compressing tablet, packing.
Embodiment 2:
1, a preparation method for Korean red ginseng chewable tablets, is characterized in that following steps:
(1) the Korean red ginseng ultrafine powder that the percentage by weight of material component is 10%, 5% hawthorn liquid extract, 5% Momordica grosvenori liquid extract, 10% milk powder, 50% sweet mellow wine powder are that filler, 6% microcrystalline cellulose or sodium carboxymethyl starch are that disintegrant, 5% Aspartame are that sweetener, 3% menthol are that freshener, 3% dolomol are that lubricant, 3% hydroxypropyl methylcellulose are that binder, appropriate 75% ethanol are wetting agent;
(2) sweet mellow wine powder in (1) and Aspartame are mixed, cross 100 mesh sieves standby;
(3) Korean red ginseng ultrafine powder, hawthorn liquid extract, Momordica grosvenori liquid extract, milk powder, microcrystalline cellulose or sodium carboxymethyl starch, menthol in (1) are mixed with sweet mellow wine powder in (2) and Aspartame, add hydroxypropyl methylcellulose and appropriate ethanol to make softwood, crossing 16 mesh sieves granulates, 60 ℃ of dry 4h, cross the whole grain of 14 mesh sieves;
(4) add dolomol to mix the particle in (3), use tablet press machine compressing tablet, packing.
Claims (1)
1. a preparation method for Korean red ginseng chewable tablets, is characterized in that following steps:
(1) Korean red ginseng ultrafine powder, the hawthorn liquid extract of 3-5%, the sweet mellow wine powder of the Momordica grosvenori liquid extract of 2-5%, 10-15% milk powder, 10-50% that the percentage by weight of material component is 5-10% is that filler, 2-30% microcrystalline cellulose or sodium carboxymethyl starch are that the Aspartame of disintegrant, 1-5% is that the menthol of sweetener, 1-3% is that the dolomol of freshener, 1-3% is that the hydroxypropyl methylcellulose of lubricant, 1-3% is that the ethanol of binder, appropriate 65-75% is wetting agent;
(2) sweet mellow wine powder in (1) and Aspartame are mixed, cross 100 mesh sieves standby;
(3) Korean red ginseng ultrafine powder, hawthorn liquid extract, Momordica grosvenori liquid extract, milk powder, microcrystalline cellulose or sodium carboxymethyl starch, menthol in (1) are mixed with sweet mellow wine powder in (2) and Aspartame, add hydroxypropyl methylcellulose and appropriate ethanol to make softwood, crossing 16 mesh sieves granulates, 50-60 ℃ of dry 3-4h, crosses the whole grain of 14 mesh sieves;
(4) add dolomol to mix the particle in (3), use tablet press machine compressing tablet, packing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005921.7A CN103719863B (en) | 2014-01-07 | 2014-01-07 | Preparation method of red ginseng chewable tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005921.7A CN103719863B (en) | 2014-01-07 | 2014-01-07 | Preparation method of red ginseng chewable tablets |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103719863A true CN103719863A (en) | 2014-04-16 |
| CN103719863B CN103719863B (en) | 2015-04-22 |
Family
ID=50444357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410005921.7A Active CN103719863B (en) | 2014-01-07 | 2014-01-07 | Preparation method of red ginseng chewable tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103719863B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104544106A (en) * | 2015-02-24 | 2015-04-29 | 刘永 | Preparation method of panacis quinquefolii radix chewable tablet |
| CN107319552A (en) * | 2017-07-04 | 2017-11-07 | 广西南宁桂知科技有限公司 | A kind of three red sweet shaddock ped chewable tablets and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1732910A (en) * | 2005-08-22 | 2006-02-15 | 南京海陵中药制药工艺技术研究有限公司 | Chewing tablet of tramado hydrochloride and its preparation method |
| KR100816064B1 (en) * | 2006-08-16 | 2008-03-24 | 주식회사 케이티앤지 | Multiple-layer tablet Comprising Korean Red Ginseng and Manufacturing method thereof |
| CN102266055A (en) * | 2011-08-16 | 2011-12-07 | 越皓 | Ginseng cream and preparation method thereof |
| CN102793733A (en) * | 2012-08-27 | 2012-11-28 | 湖南华纳大药厂有限公司 | Ginseng royal jelly chewable tablets and preparation method thereof |
| CN103053897A (en) * | 2011-10-20 | 2013-04-24 | 北京以岭药业有限公司 | Ginseng polysaccharide chewable tablet and preparation method thereof |
-
2014
- 2014-01-07 CN CN201410005921.7A patent/CN103719863B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1732910A (en) * | 2005-08-22 | 2006-02-15 | 南京海陵中药制药工艺技术研究有限公司 | Chewing tablet of tramado hydrochloride and its preparation method |
| KR100816064B1 (en) * | 2006-08-16 | 2008-03-24 | 주식회사 케이티앤지 | Multiple-layer tablet Comprising Korean Red Ginseng and Manufacturing method thereof |
| CN102266055A (en) * | 2011-08-16 | 2011-12-07 | 越皓 | Ginseng cream and preparation method thereof |
| CN103053897A (en) * | 2011-10-20 | 2013-04-24 | 北京以岭药业有限公司 | Ginseng polysaccharide chewable tablet and preparation method thereof |
| CN102793733A (en) * | 2012-08-27 | 2012-11-28 | 湖南华纳大药厂有限公司 | Ginseng royal jelly chewable tablets and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104544106A (en) * | 2015-02-24 | 2015-04-29 | 刘永 | Preparation method of panacis quinquefolii radix chewable tablet |
| CN107319552A (en) * | 2017-07-04 | 2017-11-07 | 广西南宁桂知科技有限公司 | A kind of three red sweet shaddock ped chewable tablets and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103719863B (en) | 2015-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103609992B (en) | Preparation method of Korean red ginseng cream | |
| CN103725572B (en) | Preparation method of red ginseng wine | |
| CN103720903B (en) | A kind of anti-inflammatory clearing lung-heat liver-protecting tea and preparation method thereof | |
| CN104705762A (en) | Plum juice effervescent tablet | |
| CN104720041A (en) | Spleen-tonifying and stomach-nourishing drink and production method thereof | |
| CN103749827B (en) | Preparation method of red ginseng/fig tea | |
| CN105029421A (en) | Health care product for conditioning phlegm-dampness constitution | |
| CN103719863B (en) | Preparation method of red ginseng chewable tablets | |
| CN104798950A (en) | Immune kungfu tea and preparation method thereof | |
| CN104187714B (en) | A kind of preparation method of Korean red ginseng dietary fiber swelling powder | |
| CN103704712B (en) | Preparation method of Korean red ginseng buccal tablets | |
| CN106389966B (en) | A kind of Chinese globeflower buccal tablets and preparation method thereof | |
| CN103750425B (en) | Preparation method of red ginseng/fructus momordicae soup | |
| CN103689602B (en) | Method for preparing Korean-red-ginseng oral liquid | |
| CN103564572A (en) | Preparation method of Korean red ginseng soup | |
| CN106165815A (en) | A kind of dispersing lung-QI and dissipating phlegm antiasthmatic-antitussive beverage and preparation processing method | |
| CN103710242A (en) | Semen raphani and malt wine and preparation method thereof | |
| CN104789401A (en) | Preparation method of American ginseng red-wine | |
| CN104366179A (en) | Manufacturing method of water lily stomach-strengthening lozenge | |
| CN107047868A (en) | A kind of ginger jujube tea and preparation method thereof | |
| CN106165813A (en) | A kind of warming middle-JIAO stomach invigorating treatment gastric volvulus medicated tea and preparation processing method | |
| CN105831732A (en) | Food composition for regulating qi-deficiency constitution and preparation method thereof | |
| CN104322752A (en) | Health green tea capable of relieving cough and reducing sputum | |
| CN103704459B (en) | Preparation method of Korean red ginseng hard candy | |
| CN112155109A (en) | A health candy containing Plukenetia volubilis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PP01 | Preservation of patent right | ||
| PP01 | Preservation of patent right |
Effective date of registration: 20190905 Granted publication date: 20150422 |
|
| PD01 | Discharge of preservation of patent | ||
| PD01 | Discharge of preservation of patent |
Date of cancellation: 20210905 Granted publication date: 20150422 |
|
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 264200 No. 58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee after: Shenyuanzhuang Biotechnology Co.,Ltd. Address before: No.58, Taibei Road, Lingang Economic and Technological Development Zone, Weihai City, Shandong Province Patentee before: WEIHAI HUANCUILOU RED GINSENG TECHNOLOGY Co.,Ltd. |